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Chelating agents have been used to treat lead-
exposed children since the 1950s, but the
metric for gauging therapeutic efficacy has
changed over time. When these drugs were
ﬁrst implemented for clinical use, it was com-
mon for poor, inner-city children to be
brought to emergency rooms with signs of
Pb-induced encephalopathy. The chelating
agents used at that time, CaNa2EDTA (cal-
cium disodium versenate) and BAL (dimer-
caprol), are credited with dramatically reducing
the mortality rate in such children, estimated to
be 66% before the advent of chelating agents
(Foreman 1961) relative to 1–2% thereafter
(Chisholm 1968). Fortunately, blood Pb lev-
els of U.S. children have declined dramati-
cally over the past 20 years [Centers for
Disease Control and Prevention (CDC)
2005], and Pb-induced encephalopathy is
rare. However, as evidence mounts that even
slightly elevated Pb levels are associated with
impaired cognitive functioning in children
(e.g., Canfield et al. 2003), there appears to
be growing pressure for clinicians to prescribe
chelation therapy at very low exposure levels.
The CDC (2005) and the American
Academy of Pediatrics (2005) recommend
chelation for blood Pb levels > 45 μg/dL, but
surveillance data from 10 states indicate
chelation therapy occurring at blood Pb levels
well below this recommended level (CDC,
unpublished data). 
There are surprisingly little data upon
which to gauge the beneﬁts and possible risks
of chelation therapy in children with subclini-
cal Pb poisoning. With respect to succimer
(dimercaptosuccinic acid), the most widely
administered chelating agent, only one clini-
cal trial conducted to date has included cog-
nitive measures. This study did not detect a
benefit of chelation, relative to placebo, in
children with blood Pb levels between 20 and
44 μg/dL (Dietrich et al. 2004; Rogan et al.
2001). However, several studies using animal
models reported that succimer normalized
various behaviors altered by Pb exposure,
including forced-swim immobility (Stewart
et al. 1996), activity level, and habituation
rate (Gong and Evans 1997). 
Using a rodent model of early childhood
Pb exposure, the present study was designed
to a) determine whether treatment with a
succimer regimen shown to produce signifi-
cant reductions in blood and brain Pb levels
(Cremin et al. 1999; Smith et al. 1998,
2000b; Stangle et al. 2004) also lessens the
lasting cognitive and affective changes that
are produced by a short period of early
developmental Pb exposure; and b) determine
whether succimer produces lasting cognitive
and/or affective impairment when adminis-
tered in the absence of Pb exposure. Findings
from the latter group are needed to gauge the
safety of prolonged regimens when treating
Pb-exposed children, as well as the safety of
the drug for treating autistic children, as cur-
rently advocated on numerous websites by
physicians, autism parent groups, and organi-
zations such as the American College for
Advancement in Medicine.
In this article, we describe a subset of the
administered tests—namely, a series of visual
attention tests designed to tap several functions
reported to be affected in Pb-exposed children,
including sustained and selective attention,
inhibitory control, learning/associative ability,
and regulation of arousal or emotion. Two of
these tasks, the sustained attention and selec-
tive attention tasks, are similar to ones com-
monly used to assess attention in human
subjects, such as the Continuous Performance
Test and Leonard’s 5-choice Serial Reaction
Task (reviewed by Robbins 2002). 
Materials and Methods
Study design. The study used a 3 × 2 factorial
design, with three levels of Pb exposure and
two levels of chelation (succimer or vehicle),
described below. The sample size for the
behavioral testing was 120 animals, 20 per
group. These 120 animals were the female
offspring of 60 litters, one succimer-treated
and one vehicle-treated animal per litter. All
procedures were approved by the Cornell
Institutional Animal Care and Use Committee,
and the housing facilities were accredited by the
Association for Assessment and Accreditation
of Laboratory Animal Care International.
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BACKGROUND: There is growing pressure for clinicians to prescribe chelation therapy at only
slightly elevated blood lead levels. However, very few studies have evaluated whether chelation
improves cognitive outcomes in Pb-exposed children, or whether these agents have adverse effects
that may affect brain development in the absence of Pb exposure. 
OBJECTIVES: The present study was designed to answer these questions, using a rodent model of
early childhood Pb exposure and treatment with succimer, a widely used chelating agent for the
treatment of Pb poisoning. 
RESULTS: Pb exposure produced lasting impairments in learning, attention, inhibitory control, and
arousal regulation, paralleling the areas of dysfunction seen in Pb-exposed children. Succimer treat-
ment of the Pb-exposed rats significantly improved learning, attention, and arousal regulation,
although the efﬁcacy of the treatment varied as a function of the Pb exposure level and the speciﬁc
functional deﬁcit. In contrast, succimer treatment of rats not previously exposed to Pb produced
lasting and pervasive cognitive and affective dysfunction comparable in magnitude to that produced
by the higher Pb exposure regimen. 
CONCLUSIONS: These are the ﬁrst data, to our knowledge, to show that treatment with any chelating
agent can alleviate cognitive deﬁcits due to Pb exposure. These ﬁndings suggest that it may be possible
to identify a succimer treatment protocol that improves cognitive outcomes in Pb-exposed children.
However, they also suggest that succimer treatment should be strongly discouraged for children who
do not have elevated tissue levels of Pb or other heavy metals. 
KEY WORDS: arousal regulation, attention, autism, behavior, chelation, delinquency, lead exposure,
lead poisoning, learning, succimer, treatment. Environ Health Perspect 115:201–209 (2007).
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Long-Evans rats (Harlan Sprague Dawley,
Indianapolis, IN) were mated in the labora-
tory. They were treated humanely and with
regard for alleviation of suffering. Twenty-
four hours after birth, each litter was culled to
10 pups and assigned to one of three Pb-
exposure conditions [no Pb, moderate Pb
(Mod-Pb), or high Pb (High-Pb)]. The dams
in the no-Pb group received drinking water
(deionized distilled) adulterated with 300 ppm
sodium acetate from postnatal day (PND)1 to
PND30. Both Pb-exposed groups received
water adulterated with 300 ppm Pb acetate
from PND1 to PND17. On PND17, around
the age when pups begin consuming water
directly from the drinking water bottle, the
water Pb concentration was lowered to 20 ppm
for the Mod-Pb group for the remainder of the
Pb exposure period (until PND30) in order to
maintain the moderate level of Pb intake expe-
rienced prior to PND17 when milk provided
the sole source of Pb. The High-Pb group was
maintained on the 300-ppm Pb acetate drink-
ing water until PND30. At PND30, the pups
were weaned and Pb exposure was terminated.
The period of Pb exposure, PND1–30, corre-
sponds roughly, in terms of neural develop-
ment, to the period spanning the sixth month
of pregnancy until late childhood/early adoles-
cence in humans (Bayer et al. 1993; Rice and
Barone 2000). Additional information on the
Pb exposure regimens is provided in the
Supplemental Material available online
(http://www.ehponline.org/docs/2006/9263/
suppl.pdf). 
Chelation. On PND30, the pups in each
Pb treatment group were divided into succimer
(Chemet; McNeil Consumer Products
Company, Fort Washington, PA) and vehicle
(apple juice) subgroups. This assignment was
made at the level of each litter to provide litter-
mate controls for the vehicle–succimer com-
parisons. Succimer or apple juice (vehicle) was
administered twice daily via oral gavage from
PND31 to PND52. The daily succimer dose
was 50 mg/kg body weight/day during the ﬁrst
week of chelation, followed by 25 mg/kg/day
for the second and third weeks, similar to the
regimen used clinically (Rogan et al. 2001). 
Tissue Pb analyses. On PND52 (end of
chelation therapy) one animal from each litter
was euthanized for analysis of blood and
whole brain Pb levels by inductively coupled
plasma-high resolution mass spectrometry, as
previously described (Smith et al. 2000b; see
Supplemental Material available online at
http://www.ehponline.org/docs/2006/9263/
suppl.pdf). 
Testing apparatus. Behavioral testing was
conducted in 12 automated Plexiglas cham-
bers, each operated by a personal computer.
Briefly, each chamber consisted of a waiting
area, and a small testing alcove recessed into
one wall. The alcove was separated from the
waiting area by a metal guillotine-type door.
Each of the three walls of the alcove con-
tained a funnel-shaped response port. A light-
emitting diode (LED) was mounted above
each port; the illumination of one of these
LEDs served as the discriminative cue in all of
the tasks described here. For the selective
attention task, compressed, scented air (which
served as the olfactory distractors) was pro-
jected into the response ports via polyethylene
tubes (see Gendle et al. 2003 for additional
apparatus details). 
Testing procedures. Behavioral testing
began on PND62. All animals were weighed
and tested 6 days/week. For all tasks, a daily
testing session consisted of 200 trials or 2 hr,
whichever came ﬁrst. All behavioral testing was
conducted by individuals blind to the treat-
ment condition of the subjects. Throughout
behavioral testing, animals were maintained
on a restricted food intake regimen (see
Supplemental Material available online at
http://www.ehponline.org/docs/2006/9263/
suppl.pdf) with ad libitum access to water.
Testing on the four tasks described in this
report was initiated, on average, at 9, 10, 13,
and 15 weeks of age, respectively.
Visual discrimination task. Each trial
began with the opening of the alcove door.
Immediately after the animal broke the
infrared beam at the alcove entrance, one of
the three LEDs was illuminated. The LED
remained illuminated until the animal made a
1-sec nose-poke into one of the three ports or
60 sec elapsed, whichever came ﬁrst. A 1-sec
nose-poke into the port under the illuminated
LED constituted the correct response and was
rewarded with delivery of a 45 mg food pellet
into the alcove. Each animal was tested on
this task until it reached a performance crite-
rion of at least 80% correct in a single session.
(For additional details of this task and the
subsequent attention tasks, see Gendle et al.
2003, 2004).
Visual discrimination with variable delay
(attention task 1). This task was a variation of
the visual discrimination task with two modi-
ﬁcations: a) a delay of varying duration (0, 3,
6, or 9 sec) was imposed between trial onset
(entry into the alcove) and presentation of the
cue (the illuminated LED); and b) the dura-
tion of cue illumination was shortened to
700 msec. Animals were tested on this task
for 20 sessions. 
Sustained attention task. The sustained
attention task was identical to the previous
task, except that the duration of the cue illu-
mination varied between 200, 400, and
700 msec. Animals were tested for 10 sessions
on this task. 
Selective attention task. The animals were
then tested for 10 sessions on a selective atten-
tion task, similar to the preceding task but with
modiﬁcations of the stimulus parameters and
the addition of unpredictable olfactory distrac-
tors on one-third or the trials in each daily test
session. This task was preceded by three ses-
sions on a baseline task, which had stimulus
parameters identical to those in the selective
attention task, but without olfactory distrac-
tors. In both tasks, the stimulus delay varied
between 2 and 3 sec, and the stimulus duration
varied between 300 and 700 msec. 
Statistical procedures. We analyzed the
various performance measures using a general-
ized linear mixed model (GLMM), which cor-
rectly handled the repeated measures on each
animal (Wolfinger and O’Connell 1993).
Differences were considered to be signiﬁcant
at p < 0.05; p-values between 0.05 and 0.10
were considered to be trends and are discussed
if they aid in clarifying the nature of the Pb
and succimer effects. All statistical analyses
were conducted using SAS 9.0 (SAS Institute,
Cary, NC) for Windows 2000. Additional
information on the various dependent mea-
sures and statistical analyses is provided in the
Supplemental Material available online
(http://www.ehponline.org/docs/2006/9263/
suppl.pdf).
Results
Because of space constraints, the results of
behavioral testing presented here include only
those instances where effects of Pb and/or
succimer were seen.
Comparison of the High-Pb, 
High-Pb–Succimer, and Control Groups
Visual discrimination task. Analysis of average
percent errors for the ﬁrst six sessions on the
visual discrimination task revealed a signiﬁcant
main effect of treatment group [F(2, 78.1) = 8.54;
p = 0.0004] and a significant interaction of
treatment and session number [F(10, 151) = 3.29;
p = 0.0007]. The controls (no lead exposure
and no succimer treatment) performed signiﬁ-
cantly better than the High-Pb (p = 0.017) and
High-Pb–succimer (p < 0.0001) groups.
Chelation offered no beneﬁt; the performance
of the High-Pb and High-Pb–succimer groups
did not differ signiﬁcantly. The High-Pb and
control groups did not differ signiﬁcantly by
the sixth session, indicating that their inferior
performance earlier in testing reﬂected impaired
learning ability. 
Visual discrimination with variable delay
(attention task 1). Percent premature
responses. Analysis of percent premature
responses (responses made before cue onset)
revealed a borderline main effect of treatment
[F(2, 57.2) = 2.81; p = 0.068]; and significant
interactions involving treatment and delay
[F(4, 1925) = 3.64; p = 0.006], and treatment,
session block, and trial block [F(12, 1926) = 2.13;
p = 0.013]. Rats in the High-Pb group com-
mitted a significantly higher percentage of 
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with the 3 and 6 sec pre-cue delays (averaged
across the 20 sessions on the task) (Figure 1A),
and for session blocks 3 and 4 (averaged
across pre-cue delay) (Figure 1B). Similar
trends were seen for trials with a 9-sec pre-
cue delay (Figure 1A) and for session block 2
(Figure 1B). The extent to which succimer
treatment improved performance varied
across conditions. Under some conditions
(e.g., session blocks 2 and 3), the succimer
treatment offered some beneﬁt, as the perfor-
mance of the High-Pb–succimer group was
intermediate to the control and High-Pb
groups, not differing from either one
(Figure 1B). In other conditions [e.g., pre-
cue delays 3 and 6 (Figure 1A); session
block 4 (Figure 1B)], no benefit was seen;
that is, rats in the High-Pb–succimer group
committed a significantly higher percentage
of premature responses than the controls and
did not differ from the High-Pb group. 
Alcove latency. Alcove latency (AL) is the
time elapsed between the raising of the alcove
door at trial onset and entry of the animal into
the testing alcove. Because the data were highly
skewed, with a high proportion of identical val-
ues (the minimum latency), the dependent
measures used for each animal were the per-
centages of ALs that fell into each of four bins
of latency values: < 0.1, 0.1–0.5, 0.6–1.0, and
> 1 sec. A signiﬁcant treatment × session block
interaction was found in the analysis of very
short ALS [F(6, 52.2) = 3.24; p = 0.009]. As seen
in Figure 2A, the percentage of very short ALs
(< 0.1 sec) was signiﬁcantly lower for the High-
Pb rats than for controls speciﬁcally during the
ﬁrst block of sessions (p = 0.001), suggesting
some hesitation to enter the testing alcove dur-
ing this early portion of the task when all
groups were performing very poorly. Succimer
treatment was beneficial in that the High-
Pb–succimer rats did not exhibit this hesitancy
in the ﬁrst block of sessions: they did not differ
from controls (p = 0.38) and differed signiﬁ-
cantly from the High-Pb group (p = 0.01).
Response latency. We defined response
latency as the time between cue onset and a
response. The data were log-transformed
before analysis. Analysis of the High-Pb, High-
Pb–succimer, and control groups revealed sig-
nificant interactions of treatment and delay
[F(6, 2700) = 2.70; p = 0.013], and treatment,
delay, and session block [F(18, 2700) = 1.85;
p = 0.016]. The increased response latency seen
early in the task for all animals (when error rate
was very high) was more pronounced for the
High-Pb rats than for the control and High-
Pb–succimer groups. This Pb effect was nor-
malized by succimer treatment: the High-Pb–
succimer group was signiﬁcantly faster than the
High-Pb group during these early sessions and
did not differ from controls (i.e., the same pat-
tern seen for AL, described above). 
Sustained attention task. Percent pre-
mature responses. Analysis of premature
response rate for the High-Pb, High-Pb–
succimer, and control groups revealed signiﬁ-
cant effects of treatment [F(2, 58.9) = 3.56;
p = 0.035] and treatment × delay [F(4, 114) =
2.81; p = 0.029]. The High-Pb group commit-
ted a higher percentage of premature responses
than the controls for trials with a 3-sec (p =
0.001) or 6-sec (p = 0.05) pre-cue delay
(Figure 1C). Succimer treatment did not
improve this deﬁciency in inhibitory control;
Benefits and potential risks of succimer
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Figure 1. Succimer treatment of the High-Pb rats was either ineffective or only partially effective in allevi-
ating the impairments in learning, inhibitory control, and early-session attentional function. Percent pre-
mature responses in attention task 1 as a function of (A) the duration of the pre-cue delay (averaged
across the 20 sessions) and (B) stage of testing (averaged across the pre-cue delay). (C) Percent pre-
mature responses in the sustained attention task as a function of the duration of the delay between trial
onset and cue presentation. (D) Percent omission errors committed during the ﬁrst block of trials in each
session (trials 1–66) in the sustained attention task as a function of cue duration (slopes for High-Pb vs.
control; p = 0.009). Data points are means ± SEs.
*p ≤ 0.07. **p < 0.05. #p ≤ 0.01. 
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**the High-Pb–succimer group was signifi-
cantly different from controls for the 3-sec
(p = 0.001) and 6-sec (p = 0.02) delays and
was not different from the High-Pb group for
either. 
Percent omission errors. An omission
error was tallied when a rat entered the testing
alcove but failed to respond within 15 sec of
trial onset, indicative of missing the cue. The
analysis of percent omission errors for the
High-Pb, High-Pb–succimer, and control
groups revealed the following significant
treatment-related effects: treatment × trial
block [F (4, 107) = 2.91; p = 0.025], treatment
× trial block × cue duration [F(12, 872) = 1.75;
p = 0.05], and treatment × trial block × previ-
ous trial outcome (Prev) [F (4, 892) = 6.63;
p < 0.0001]. For all groups, we found an
increase in percent omission errors across
each session, an effect that was most pro-
nounced for trials that followed an error. As
shown in Figure 2B, for trials following an
error, the rate of increase in omission errors
across each session was greater for the High-
Pb rats than for controls. This impairment
was abolished by succimer treatment: The
High-Pb–succimer group was significantly
different from the High-Pb-group and did
not differ from controls. 
The significant interaction of treatment,
trial block, and cue duration [F(12, 872) =
1.75; p = 0.05] reﬂected that a) the High-Pb
rats committed a borderline greater percent
omission errors than controls in the first
block of trials in each session (p = 0.06), and
b) during this ﬁrst block of trials in each ses-
sion (trials 1–66), the High-Pb group bene-
ﬁted less than controls by the lengthening of
the cue from 200 to 700 msec (p = 0.009),
such that group differences were greatest on
trials with the longest cue duration (p = 0.01,
for 700 msec cue; Figure 1D). Succimer
treatment provided some benefit, as the
High-Pb–succimer group did not differ sig-
niﬁcantly from controls in this regard; how-
ever, they also did not differ significantly
from the High-Pb group. 
Additional details of the omission error
analyses are provided in the Supplemental
Material available online (http://www.
ehponline.org/docs/2006/9263/suppl.pdf). 
Comparison of the Mod-Pb, Mod-Pb–
Succimer, and Control Groups 
Visual discrimination task. Analysis of average
percent errors for the ﬁrst six sessions on the
task revealed a signiﬁcant main effect of treat-
ment group (F(2, 78.1) = 4.88; p = 0.01) and a
signiﬁcant interaction of treatment and session
[F(10, 159) = 1.93; p = 0.04]. The Mod-Pb
group learned signiﬁcantly more slowly than
controls (main effect contrast, p = 0.004).
Chelation offered a signiﬁcant beneﬁt in that
the Mod-Pb–succimer group learned signifi-
cantly faster than the Mod-Pb group (main
effect contrast, p = 0.03) and did not differ
from controls for any session. The three groups
performed similarly by the sixth session, indi-
cating that the observed group differences in
performance reflected variations in learning
ability (Figure 3A).
Visual discrimination with variable delay
(attention task 1). The analysis of percent
premature responses revealed a significant
interaction of treatment and session block
[F(6, 58.9) = 2.89; p = 0.016]. As depicted in
Figure 3B, the Mod-Pb group mastered the
new rule (i.e., that the light cue was pre-
sented after a delay on some trials) more
slowly than controls (p = 0.05), and succimer
treatment offered a signiﬁcant beneﬁt (Mod-
Pb vs. Mod-Pb–succimer, session block 1,
p = 0.006). The Mod-Pb–succimer and con-
trol groups did not differ for any session. The
performance of the three groups did not dif-
fer during the final 10 sessions on the task
(blocks 3 and 4), indicating that the observed
performance differences reflected differing
learning ability. 
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Figure 3. Succimer treatment signiﬁcantly improved learning ability of the Mod-Pb rats. (A) Visual discrimi-
nation task (Mod-Pb–succimer vs. Mod-Pb; main effect contrast, p = 0.03). (B) Attention task 1. Data points
are means ± SEs.
*p = 0.056; **p ≤ 0.03; #p < 0.01, Mod-Pb vs. control. ##p = 0.03; †p = 0.006, Mod-Pb–succimer vs. Mod-Pb. 
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Visual discrimination task. Analysis of average
percent errors for the ﬁrst six sessions on the
task revealed that the succimer-only group
(treated with succimer in the absence of lead
exposure) learned significantly more slowly
than the controls [Figure 4A; treatment
(F(1, 57) = 4.21; p = 0.04); treatment × session
(F(5, 99.4) = 2.20; p = 0.06)]. 
Attention task 1. The percentage of inaccu-
rate responses (responses made after cue onset,
but to an incorrect port) was significantly
higher for the succimer-only group than for
controls during session blocks 2, 3, and 4
[Figure 4B; treatment, (F(1, 141) = 4.42;
p = 0.042); treatment × session block (F(3,
1729) = 2.64; p = 0.048)]. The groups did not
differ signiﬁcantly for this type of error during
session block 1 (sessions 1–5), an early point in
the learning process when most responses were
made before cue onset (premature responses). 
Sustained attention task. Percent omis-
sion errors. The analysis of omission errors for
the control and succimer-only groups revealed
significant interactions of treatment and cue
duration [F(2, 587) = 4.47; p = 0.012] and of
treatment, cue duration, and trial block
[F(8, 587) = 1.99; p = 0.045]. As shown in
Figure 4C, the succimer-only group beneﬁted
less than controls by the lengthening of the cue
from 200 to 700 msec (p = 0.004). This pattern
was seen only during the beginning and end of
each daily session (contrasts for slopes across
cue duration, p = 0.002 and 0.037 for ﬁrst and
third trial blocks, respectively). 
Percent inaccurate responses. The suc-
cimer-only group beneﬁted less than controls
from the lengthening of the cue, resulting in
increasing group differences in percent inac-
curate responses as the cue duration increased
[F(2, 1292) = 15.95; p < 0.0001].
Selective attention task. Because the tim-
ing of the distractor relative to cue onset (1 or
2 sec) did not alter the treatment-related
effects, we used a two-level variable for dis-
traction condition for the analyses: distractor
or no distractor. 
The analysis of percent inaccurate responses
for the succimer-only and control groups
revealed a main effect of treatment group
[F(1, 38.1) = 6.18; p = 0.017], an interaction of
treatment and cue duration [F(1, 216) = 11.25;
p = 0.0009], and a trend toward a three-way
interaction of treatment, distraction condi-
tion, and the outcome of the previous trial
[F(1, 387) = 3.06, p = 0.08]. The succimer-only
group beneﬁted less by the lengthening of the
cue than did controls (Figure 5C). In addi-
tion, although the succimer-only group com-
mitted a higher percentage of inaccurate
responses overall (p = 0.017), group differ-
ences were greatest for trials that both
included a distractor and that followed an
error (Figure 5A,B). However, there was also a
tendency for the groups to differ on non-
distraction trials (p = 0.10; Figure 5A). To
assess whether the trend toward poorer perfor-
mance of the succimer-only group on the
nondistraction trials reﬂected generalized dis-
ruption caused by the unpredictable presenta-
tion of the olfactory distractors, an analysis
was conducted to directly compare perfor-
mance on the nondistraction trials with that of
the preceding baseline task. All trials in this
latter task were identical to the nondistraction
trials of the selective attention task (i.e., pre-
cue delays, cue durations, etc.). For the suc-
cimer-only group, the percentage of inaccurate
responses was signiﬁcantly higher for the non-
distraction trials of the selective attention task
than during the baseline task (p = 0.0001),
whereas for controls, the rates were similar for
these two conditions (p = 0.16; Figure 5D).
This analysis supports the inference that for
the succimer-only group, the unpredictable
presentation of the olfactory distractors pro-
duced a generalized disruption in performance
that extended beyond the distraction trials. 
Motivation. Motivation was assessed by
analyzing the average rate of response trials
[number of response trials per session divided
by session length (minutes)]. No significant
group differences were detected (all p > 0.2),
providing evidence that motivational differ-
ences did not account for the observed differ-
ences in performance (for further discussion,
see Supplemental Material available online at
http://www.ehponline.org/docs/2006/9263/
suppl.pdf). 
Blood and brain Pb levels. Analysis of
mean blood Pb levels on PND52 revealed
dose-dependent effects on both blood and
brain Pb levels and a beneﬁcial effect of suc-
cimer chelation for both Pb exposure condi-
tions for both tissues (Table 1). 
Body weight and general health. The
High-Pb and High-Pb–succimer groups
weighed ≈ 6% less than the control group
(p < 0.05), measured on PND52 after cessa-
tion of succimer treatment. None of the other
groups differed from controls. The slightly
smaller size of the High-Pb rats likely reﬂects
a decrease in growth hormone during the Pb
Benefits and potential risks of succimer
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Figure 5. Succimer treatment of the non-Pb-exposed rats impaired performance in the selective attention
task. Percent inaccurate responses in the selective attention task, as a function of whether or not a dis-
tractor was presented on the current trial and whether the prior trial was correct (A) or incorrect (B).
(C) Percent inaccurate responses in the selective attention task, plotted as a function of cue duration.
(D) Percent inaccurate responses in the baseline task and the nondistraction trials of the selective atten-
tion task (see text). Data shown are means ± SEs.
*p = 0.02; **p < 0.01, succimer-only vs. controls.
25
20
15
10
5
0
Nondistraction
I
n
a
c
c
u
r
a
t
e
 
r
e
s
p
o
n
s
e
s
 
(
%
)
*
300 700
Cue duration (msec)
A B
C D
Distraction Distraction Nondistraction
25
20
15
10
5
0
I
n
a
c
c
u
r
a
t
e
 
r
e
s
p
o
n
s
e
s
 
(
%
)
**
25
20
15
10
5
0
I
n
a
c
c
u
r
a
t
e
 
r
e
s
p
o
n
s
e
s
 
(
%
)
**
25
20
15
10
5
0
I
n
a
c
c
u
r
a
t
e
 
r
e
s
p
o
n
s
e
s
 
(
%
)
Baseline task Nondistraction
trials
Control
Succimer-only
Table 1. Mean ± SE blood and brain Pb levels at
PND52 (end of succimer treatment). 
Blood Pb  Brain Pb 
Group (µg/dL) (ng/g dw)a
Control 1.5 ± 0.1 41 ± 9
Mod-Pb 12.6 ± 0.8* 1,040 ± 49*
High-Pb  31.0 ± 0.8** 3,690 ± 260**
Mod-Pb–succimer 2.8 ± 0.2# 196 ± 14.2#
High-Pb–succimer 8.5 ± 0.7## 1,370 ± 150##
n = 7–11 animals per group. 
ang Pb/g dry tissue. *p < 0.005; **p < 0.0001, Pb-exposed
(nonchelated) groups vs. control. #p < 0.003 for both blood
and brain, Mod-Pb–succimer vs. Mod-Pb. ##p < 0.0001 for
both blood and brain, High-Pb–succimer vs. High-Pb.exposure period (e.g., Ronis et al. 1998; see
Supplemental Material available online at
http://www.ehponline.org/docs/2006/9263/
suppl.pdf). Low-level Pb exposure in children
has also been associated with small but statis-
tically signiﬁcant reductions in height, in the
absence of any other signs of overt toxicity
(e.g., Shukla et al. 1991). 
Discussion
A short period of early Pb exposure produced
impairments in learning, attention, inhibitory
control, and arousal regulation, paralleling the
areas of dysfunction seen in children with low
to moderate elevations in blood Pb levels. As in
children, these impairments were lasting; that
is, they were apparent long past the period of
Pb exposure, indicative of lasting neurologic
dysfunction as a result of the early exposure.
The pervasiveness of the impairment was
related to the intensity of Pb exposure; for the
Mod-Pb group, dysfunction was limited to
learning ability, whereas the High-Pb group
exhibited impairments in learning, inhibitory
control, arousal regulation, and attention.
Importantly, succimer treatment signiﬁcantly
alleviated some Pb-induced neurobehavioral
deﬁcits, although the magnitude of the beneﬁt
varied as a function of both the level of the Pb
exposure and the speciﬁc area of dysfunction.
In contrast, succimer treatment of rats not pre-
viously exposed to Pb produced lasting cogni-
tive and affective dysfunction, similar in
magnitude and pervasiveness to that produced
by the High-Pb exposure regimen. The basis
for each of these conclusions is provided below
and summarized in Table 2. 
Pb-induced learning deficits and efficacy
of succimer treatment. Both the High-Pb and
Mod-Pb groups learned the basic rules of the
visual discrimination task and attention task 1
more slowly than the controls, indicating last-
ing impairment in associative ability as a result
of a short period of early Pb exposure, as pre-
viously reported (e.g., Garavan et al. 2000).
Succimer treatment of the Pb-exposed animals
improved learning rate, although the degree of
beneﬁt was greater for the Mod-Pb group than
for the High-Pb group. Succimer treatment
signiﬁcantly improved the learning rate of the
rats in the Mod-Pb group for both the initial
visual discrimination task and attention task 1;
in both tasks, the Mod-Pb–succimer group
learned significantly faster than the Mod-Pb
group and did not differ signiﬁcantly from the
controls. For the High-Pb exposure regimen,
succimer treatment did not improve learning
rate in the visual discrimination task, but a
small beneﬁt was seen in attention task 1. It is
likely that more prolonged succimer treatment
would have produced an even greater cogni-
tive beneﬁt for these more heavily exposed ani-
mals. This suggestion is based on the facts that
a) reductions in brain Pb levels lag signifi-
cantly behind reductions in blood Pb follow-
ing chelation or cessation of Pb exposure
(Cremin et al. 1999; Smith et al. 1998;
Stangle et al. 2004); b) blood and brain Pb
levels were still quite elevated in the High-Pb
group at the end of chelation (approximately
equal to the nonchelated Mod-Pb rats); and
c) in a previous study from our laboratory, a
second 3-week succimer regimen offered
signiﬁcant beneﬁt over one regimen in terms
of both blood and brain Pb reductions
(Stangle et al. 2004). Therefore, these results
likely underestimate the potential benefit of
succimer treatment for the more heavily
Pb-exposed animals. 
Heightened reaction to errors in the Pb-
exposed rats is abolished by succimer treat-
ment. For the four tasks presented here, the
rate of all types of errors was significantly
greater on trials that followed an error than on
trials following a correct response. Similarly,
the latency to enter the testing alcove at trial
onset was signiﬁcantly longer on trials follow-
ing an error than on trials that followed a cor-
rect response, a pattern also seen for the
latency to make a response after cue onset.
The disruption produced by committing an
error was signiﬁcantly greater for the High-Pb
animals than for controls for several depen-
dent measures: In the sustained attention task,
the percentage of omission errors was signiﬁ-
cantly higher for the High-Pb group than for
controls during mid- to late-session trials fol-
lowing an error—but not following a correct
response—a pattern that indicates the com-
bined influences of the disruptive effects of
committing an error and the changing motiva-
tional and attentional state of the animals
across each session. Similarly, in attention
task 1, the High-Pb rats took significantly
longer to enter the testing alcove and to make
a response than controls, but only early in the
task when error rate was very high and the rats
had not yet learned the task rules. Finally, the
drop in performance on trials following an
error was also more pronounced for the High-
Pb rats than for controls in a conditional
olfactory discrimination task with periodic
reward omission, an additional task adminis-
tered subsequently to these rats (Beaudin
et al. 2006). 
The interpretation of the heightened sensi-
tivity to errors of the High-Pb rats is informed
by previous studies that examined performance
changes as a function of an error on the previ-
ous trial, all involving human subjects. In some
of these studies, the error rate on post-error
trials was exceptionally low (e.g., Laming
1979; Robertson et al. 1997), indicating the
operation of an executive error-correction sys-
tem localized to the anterior cingulate cortex
(e.g., Bush et al. 2000; Fernandez-Duque et al.
2000). However, the ﬁnding consistently seen
in our rodent studies—increased error rate on
trials following an error (reviewed by Strupp
and Beaudin 2006)—has also been reported in
some human studies (e.g., Elliott et al. 1996;
Rabbitt and Rodgers 1977) and likely reﬂects
Stangle et al.
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Table 2. Each of the areas of impairment seen in the High-Pb, Mod-Pb, and succimer-only groups, fol-
lowed by the speciﬁc ﬁnding upon which the functional inference is based. 
Area of dysfunction (speciﬁc measure) Alleviated by succimer?
High-Pb group 
Impaired learning ability
Visual discrimination task: rate of decline of percent errors N
Attention task 1: rate of decline of percent premature responses  I
Impaired Inhibitory control
Attention task 1: increased percent premature responses in ﬁnal block of sessions N
Sustained attention task: percent premature responses (throughout all sessions) N
Increased disruption following errors (impaired arousal regulation)
Attention task 1: increased alcove latency in ﬁrst block of sessions Y
Attention task 1: increased response latency in ﬁrst block of sessions  Y
Sustained attention task: increased omission errors on post-error trials Y
Lapses in attention (pattern of group differences as a function of cue duration) I
Early session increase in omission errors (transition problems → attention dysfunction)  I
Mod-Pb Group
Impaired learning ability
Visual discrimination task: rate of decline of percent errors Y
Attention task 1: rate of decline of percent premature responses  Y
Succimer-only group
Impaired learning ability: visual discrimination task (rate of decline of percent errors)
Attentional dysfunction: attention task 1 (increased percent inaccurate responses)
Lapses in attention (pattern of effects as a function of cue duration)
Sustained attention task
Selective attention task 
Impaired arousal regulation
Selective attention task: group differences greatest on post-error distraction trials 
Higher rate of errors on nondistraction trials in selective attention task than in baseline task
For the High-Pb and Mod-Pb groups, the right-hand column indicates whether succimer treatment signiﬁcantly alleviated
the dysfunction (Y), did not significantly alleviate dysfunction (N), or produced a level of performance that was inter-
mediate (I; i.e., not signiﬁcantly different from either the control group or their vehicle-treated counterparts).Benefits and potential risks of succimer
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an emotional response to the error. This inter-
pretation is supported by the ﬁnding that an
electrophysiologic marker of error detection,
termed error-related negativity, varies as a
function of individual differences in negative
affect and emotionality (e.g., Luu et al. 2000;
also see Beaudin et al. 2006).
Importantly, this heightened disruption
following an error was very responsive to suc-
cimer treatment: In all cases, the High-Pb–
succimer group was indistinguishable from
controls (Figure 2; Beaudin et al. 2006).
These results provide encouragement that Pb-
induced dysfunction in the area of arousal or
emotion regulation can be signiﬁcantly allevi-
ated by succimer treatment. This type of dys-
function may be an important contributor of
the behavioral problems and increased delin-
quency rates seen in Pb-exposed children and
adolescents (e.g., Bellinger et al. 1994;
Dietrich et al. 2001; Needleman et al. 1996),
based on evidence that individuals vulnerable
to faulty regulation of negative emotion are at
risk for violence and aggression (Davidson
et al. 2000). 
Succimer was effective in alleviating some,
but not all, types of Pb-induced attentional
dysfunction. The sustained attention task
revealed two types of attentional dysfunction
in the High-Pb group. First, the early-session
increase in omission errors (relative to mid-
session), seen for all groups across all sessions
on this task, was more pronounced for the
High-Pb group than for the controls, with
group differences being largest for trials with
the longest cue duration (700 msec). This
pattern of results may indicate that lapses in
attention were more common for the High-
Pb rats than for controls during this early part
of the session. More frequent attentional
lapses in the High-Pb group would have the
consequence of ﬂattening the slope across cue
duration and making group differences largest
on trials for which performance of the con-
trols was best (i.e., those with the longest
cues). One interpretation of this pattern is
that early Pb exposure may impair the ability
to rapidly engage in a new task when transi-
tioning between activities, manifested here as
an increased tendency to miss the cue (an
attentional deﬁcit). 
A second type of attentional dysfunction
observed in the High-Pb rats was evident later
in each testing session. The incidence of
omission errors increased for all groups across
each daily testing session, the classic pattern
seen when sustained attention is taxed
(Parasuraman and Warm 1998). However, as
discussed above, the High-Pb rats committed a
significantly higher percentage of omission
errors than controls during mid- to late-session
trials, specifically on trials that followed an
error. This pattern of effects, coupled with the
similar pattern seen in the omission of reward
task administered subsequently to these same
animals (Beaudin et al. 2006), indicates that
as attention and motivation waned across the
session, the disruptive effect of an error on
attention and persistence increased, and that
this disruption was more pronounced for the
Pb-exposed rats than for controls. 
The effectiveness of succimer chelation var-
ied for these different types of attentional
deficits. As discussed above, the heightened
attentional disruption seen in the High-Pb rats
following an error was completely normalized
by succimer treatment, as the chelated High-
Pb rats differed signiﬁcantly from the High-Pb
group and did not differ from controls. In con-
trast, succimer treatment only partially allevi-
ated the attentional lapses seen early in each
test session; the High-Pb–succimer group was
intermediate to the other two, not differing
from either. 
Deficient inhibitory control in the
High-Pb rats. In the sustained attention task,
the percentage of premature responses was
signiﬁcantly higher for the High-Pb rats than
for controls, indicating deficient inhibitory
control. Converging evidence for this area of
dysfunction was provided by the higher per-
centage of premature responses committed by
the High-Pb rats in the ﬁnal block of trials of
attention task 1, a point at which the basic
rules of the task had already been learned.
Succimer treatment was ineffective in alleviat-
ing this area of dysfunction: In both instances,
the percentage of premature responses for the
High-Pb–succimer rats was significantly
greater than that of the control rats, and not
different from the High-Pb group.
Pattern of succimer effects in the Pb-
exposed animals. The efﬁcacy of the succimer
treatment varied as a function of both the
level of Pb exposure and the specific func-
tional domain tested. Interestingly, the pat-
tern seen for succimer efficacy parallels the
apparent sensitivity of specific functional
domains to the Pb exposure. Learning was
impaired by both Pb exposure regimens,
whereas impaired regulation of arousal or
emotion was seen only in the High-Pb group,
suggesting that disruption in learning occurs
at lower exposures than dysregulation of
arousal or emotion. The efﬁcacy of succimer
across these domains corresponded to the
degree to which chelation reduced brain Pb
levels in the two Pb exposure groups. For the
Mod-Pb group, succimer treatment almost
completely removed Pb from the brain and
effectively alleviated the learning dysfunction.
In contrast, brain Pb levels were still moder-
ately elevated in the High-Pb group following
chelation; these chelated High-Pb rats exhib-
ited the same pattern of dysfunction as the
unchelated Mod-Pb group, which also had
moderately elevated brain Pb levels on
PND52. Both groups also exhibited impaired
learning but not affective dysfunction. This
constellation of findings suggests that suc-
cimer treatment of the High-Pb rats reduced
tissue (i.e., brain) Pb levels below that which
produces lasting impairment in emotion regu-
lation, but not enough to alleviate the learn-
ing dysfunction. 
The mechanistic basis for this pattern of
effects is unknown, but likely reﬂects complex
interactions between the timing of the Pb
exposure and succimer treatment relative to
the ontogenetic stage of specific neural sys-
tems, the extent to which succimer treatment
reduced Pb levels in specific neural systems
(Cremin et al. 1999), and the inherent sensi-
tivity of those developmental processes and/or
associated functional domains to Pb exposure. 
Effects of succimer in the absence of Pb
exposure. The present study also revealed the
unexpected ﬁnding that a single 3-week course
of succimer treatment during early develop-
ment produced lasting dysfunction in cogni-
tion and arousal regulation in rats not
previously exposed to Pb. Note that these four
behavioral tests were administered across a
7-month period following cessation of suc-
cimer treatment, suggesting lasting brain
changes. These results corroborate preliminary
results from a similar study in nonhuman pri-
mates (Laughlin 2001). The succimer-only
group learned the initial visual discrimination
task more slowly than the controls. They also
committed a higher rate of inaccurate
responses than controls in attention task 1,
indicative of attentional dysfunction. In both
the sustained attention task and the selective
attention task, their performance benefited
less by the lengthening of the visual cue than
did the controls, indicative of lapses in atten-
tion, as discussed above. Additionally, in the
selective attention task, the succimer-only
group committed a higher rate of inaccurate
responses than controls, an effect that was
most pronounced for trials on which a dis-
tractor was presented and that followed an
error, indicating impairments in both selec-
tive attention and arousal regulation. Finally,
a comparison of performance on trials without
distractors (during the selective attention task)
to performance on the baseline task revealed
that the succimer-only rats experienced a gen-
eralized disruption of performance in the selec-
tive attention task that extended beyond the
trials on which a distractor was presented. This
ﬁnding, too, implicates impaired arousal regu-
lation in the succimer-only group. These vari-
ous impairments were similar in magnitude to
those produced by the High-Pb exposure. 
The mechanism(s) responsible for these
adverse succimer effects is not known. One
possibility is that succimer, a metal-chelating
agent, altered essential metal homeostasis and
increased metal diuresis, as has been suggested
by a number of clinical and nonhuman primate studies (Aposhian et al. 1989; Fournier
et al. 1988; Smith et al. 2000a).
Extrapolation of treatment regimens to
humans. Both Pb-exposed groups exhibited
low blood Pb levels (≈ 25–35 μg/dL) during
the first 3 weeks of the 4-week exposure
period. During the fourth and final week of
exposure, both groups experienced an increase
in tissue Pb levels because of the direct inges-
tion of Pb-adulterated water. Although the
blood Pb levels produced during this final
week of exposure were higher than commonly
reported for children (see Supplemental
materials available online at http://www.
ehponline.org/docs/2006/9263/suppl.pdf),
direct comparison of blood Pb levels across
species should be cautioned. The available
evidence indicates that the blood Pb levels
required to produce overt toxicity (i.e.,
malaise, coma, convulsions, death) or lasting
neurobehavioral effects (i.e., effects that last
beyond the period of exposure) are higher in
both rats and nonhuman primates than in
humans (Garavan et al. 2000; Levin and
Bowman 1986; Morgan et al. 2001; Rice
1988). Consistent with these earlier studies,
none of the animals in the present study
exhibited any signs of overt toxicity through-
out the study and could not be distinguished
from controls throughout the 8 months of
daily handling. The Mod-Pb group exhibited
very circumscribed and subtle behavioral/cog-
nitive effects, and the High-Pb group exhib-
ited subtle, although more widespread,
neurobehavioral effects. As such, the regimens
used in the present study may be viewed as
modeling subclinical or asymptomatic Pb
exposure. Similarly, although the succimer
regimen used in the present study closely
modeled the duration and dose (weight-nor-
malized) of the regimens used clinically in
children, it is possible that it was more
“aggressive” than the clinical regimen, when
allometrically scaled across species. 
Summary and Implications 
The present study provides clear evidence that
administration of succimer, using a regimen
sufﬁcient to reduce brain Pb levels, can lessen
Pb-induced impairments in learning ability,
attention, and regulation of arousal and/or
emotion. These are the first data, to our
knowledge, to show that treatment with any
chelating agent can alleviate cognitive deﬁcits
caused by Pb exposure. The primary area of
dysfunction seen in the Mod-Pb rats, impaired
learning ability, was signiﬁcantly alleviated by
succimer treatment. For the High-Pb group,
treatment with succimer provided a robust
benefit on measures indicative of impaired
regulation of arousal or affect—one of the
most pervasive areas of impairment seen in
this group, and a major cause of their
impaired performance overall. However, for
the High-Pb group, succimer produced only a
slight improvement in learning ability and did
not lessen the deficient inhibitory control.
The High-Pb rats treated with succimer per-
formed similarly to non-chelated Mod-Pb
rats—consistent with their comparable brain
Pb levels—suggesting that a more prolonged
treatment may have further improved perfor-
mance in the High-Pb exposed animals. 
These ﬁndings are consistent with previous
animal studies but contrast with the results of
the Treatment of Lead-Exposed Children
(TLC) study, the one clinical trial in Pb-
exposed children that included cognitive out-
comes (Dietrich et al. 2004; Rogan et al.
2001). There are several possible reasons for
this disparity in outcomes. First, the succimer
treatment protocol used in the TLC trial may
not have achieved a sufficient reduction in
brain Pb levels to improve cognitive function-
ing. This suggestion is based on the evidence
that a) succimer-induced reductions in blood
Pb overestimate reductions in brain lead
(Cremin et al. 1999; Smith et al. 1998; Stangle
et al. 2004) and b) the succimer treatment pro-
tocol used in the TLC study achieved relatively
modest group differences in blood Pb levels
(relative to placebo), averaging only 4.5 μg/dL
over the 6 months following treatment (Rogan
et al. 2001). In comparison, in the present
study both blood and brain Pb levels were
substantially reduced by succimer, relative to
the vehicle treatment (Table 1). Second, the
disparate outcomes of the TLC trial and the
present study may also reflect differences in
the nature of the cognitive tasks that were
used. In particular, the tasks used here (rela-
tive to those in the TLC trial) may have pro-
vided more specific indices of the two
functional domains most improved by suc-
cimer in the present study: associative learn-
ing ability and regulation of arousal and/or
emotion (indexed by reactivity to errors).
In conclusion, this study demonstrates
that it is possible for chelation therapy to alle-
viate certain types of Pb-induced behavioral/
cognitive dysfunction in rats. This is an
important demonstration because Pb-induced
behavioral dysfunction is generally considered
to be irreversible (e.g., Needleman et al.
1996). The present ﬁndings thus suggest that
if a succimer treatment protocol that pro-
duced a substantial removal of Pb from the
brain could be identiﬁed for humans, a func-
tional beneﬁt might be derived. In addition,
the finding that succimer produced lasting
adverse effects when administered to non-
Pb–exposed rats highlights the potential risks
of administering succimer or other metal
chelating agents to children who do not have
elevated tissue Pb levels. It is of significant
concern that this type of therapy is being
widely advocated as safe and effective for
treating autism.
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